- Investing Ideas
- /
- Belgian Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Belgian Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Results
3
0 new
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
3 companies
Hyloris Pharmaceuticals
Market Cap: €162.4m
Engages in the research, development, and manufacture of pharmaceutical products to address medical needs.
HYL
€5.80
7D
-5.2%
1Y
-50.4%
UCB
Market Cap: €31.1b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€163.45
7D
0.4%
1Y
18.6%
argenx
Market Cap: €30.7b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€502.60
7D
-2.6%
1Y
39.3%